FDA approves Welireg (belzutifan) to treat advanced, unresectable, or metastatic pheochromocytoma and paraganglioma – Merck Inc
Merck Inc., (known as MSD outside of the United States and Canada), announced the FDA has accepted for priority review a supplemental new drug application (sNDA) seeking approval… read more.
